Paraluman S Leonin - FDA Investigator Report

Overview Statistics

46
Total Inspections
19
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 5 days
Shortest Inspection: 1 days
Average Length: 0.4 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Paraluman S Leonin's Recent Inspections

DateCompanyCityCountryFEI Number483
2013-04-22Underwriters LaboratoriesCantonUnited States1216976
2013-03-15Denison Pharmaceuticals, LLCLincolnUnited States1210580
2013-01-17TGA Sciences, Inc.MedfordUnited States3002966869
2012-11-20Vapco IncorporatedLawrenceUnited States1219408
2012-09-20Beth Israel Deaconess Medical Center IRBBostonUnited States1219208
2012-08-02Vertex Pharmaceuticals IncorporatedBostonUnited States1000513211
2012-06-08Momenta Pharmaceuticals, Inc.CambridgeUnited States3005948218
2012-04-18DUSA Pharmaceuticals, Inc.BillericaUnited States3002513708
2012-03-14American Gas Products LLCEverettUnited States3005704952
2011-12-09Cubist Pharmaceuticals, Inc.LexingtonUnited States1000513172

Sign Up to get the complete report.

Download 483s and EIRs for Paraluman S Leonin

Paraluman S Leonin - Co-Inspectors

NameInspectionsLast Inspection
Kenneth H Williams92013
Felix Maldonado42008
Javier O Vega32011
Luella J Rossi32010
Michele L Obert22009
Valentino Fiorella12009

Paraluman S Leonin's Active Locations

  • United States
  • Germany
  • Russia
  • Ireland
  • Taiwan
  • Italy
  • China
  • Switzerland

Paraluman S Leonin's Year-wise Inspection Count

  • 2008:9 inspections
  • 2009:9 inspections
  • 2010:10 inspections
  • 2011:9 inspections
  • 2012:6 inspections
  • 2013:3 inspections
Last Updated: 2025-05-14 06:11:22